Abstract
To explore the efficacy and safety of G-SCF-mobilized donor lymphocyte infusion (DLI) for treatment of relapse of hematologic malignancies after allog......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
